Iterum Therapeutics plc (Nasdaq: ITRM), a company focused on delivering next generation oral and IV antibiotics to treat infections caused by multi-drug resistant pathogens in both community and ...

CI Global Asset Management has received 34 FundGrade A+® Awards, which recognize the "best of the best" in Canadian investment funds.

Net income for the fourth quarter of 2024 was $154.8 million, or $0.23 per diluted share, compared to $133.4 million, or $0.22 per diluted share, for the fourth quarter of 2023. This 4.5% increase per ...